<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01083745</url>
  </required_header>
  <id_info>
    <org_study_id>022-10</org_study_id>
    <nct_id>NCT01083745</nct_id>
  </id_info>
  <brief_title>Assessment of Blood and Follicular Fluid Immune Cell Constitution in Patients Undergoing in Vitro Fertilization</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hillel Yaffe Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hillel Yaffe Medical Center</source>
  <brief_summary>
    <textblock>
      The etiology of infertility in the majority of patients with poor response to ovarian&#xD;
      stimulation remains unknown. This study will investigate the role of immune cells (T cells, B&#xD;
      cells, dendritic cells and NK cells), that constitute the immune system which normally fights&#xD;
      infection and cancer. We, the investigators, have found that specialized NK cells that help&#xD;
      with new blood vessel formation, are found in the fluid surrounding the egg during IVF, only&#xD;
      in patients with good response to ovarian stimulation. We now wish to expand our studies and&#xD;
      correlate our findings to ovarian blood flow , as measured by 3D ultrasound and to the&#xD;
      presence of other cells in the immune system.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <condition>Infertility, Female</condition>
  <arm_group>
    <arm_group_label>IVF patients - 1</arm_group_label>
    <description>Poor responders</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IVF patients - 2</arm_group_label>
    <description>Good responders</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        IVF clinic patients in tertiary care center&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 27-43 years&#xD;
&#xD;
          -  Diagnosis of infertility due to endometriosis, severe male factor, tubal occlusion.&#xD;
&#xD;
          -  Patient undergoing IVF&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Body mass index (BMI) &gt; 38 kg/m2&#xD;
&#xD;
          -  Abnormal uterine cavity as evidenced by sonohysterogram or hysterosalpingography&#xD;
&#xD;
          -  Any current use of systemic steroid medication or any infertility treatment within 3&#xD;
             months of study enrollment.&#xD;
&#xD;
          -  Any contraindication to being pregnant and carrying a pregnancy to term.&#xD;
&#xD;
          -  Any ovarian or abdominal abnormality that may interfere with adequate TVS evaluation.&#xD;
&#xD;
          -  Absence of one or two ovaries&#xD;
&#xD;
          -  Clinically relevant systemic disease (e.g., Insulin-dependent diabetes, adrenal&#xD;
             dysfunction, organic intracranial lesion, polycystic ovarian syndrome,&#xD;
             hyperprolactinemia, or hypothalamic tumor) or serious illness (Neoplasia).&#xD;
&#xD;
          -  History (within past 12 months) or current abuse of alcohol or drugs.&#xD;
&#xD;
          -  Administration of any investigational drugs within three months prior to study&#xD;
             enrollment.&#xD;
&#xD;
          -  Any medical condition that may interfere with the absorption, distribution, metabolism&#xD;
             or excretion of the study drugs, gastrointestinal diseases, mal absorption syndromes&#xD;
             and liver dysfunction&#xD;
&#xD;
          -  Unexplained gynecological bleeding.&#xD;
&#xD;
          -  Ejaculated sperm is not sufficient for ICSI&#xD;
&#xD;
          -  Patient not able to communicate adequately with the investigators and to comply with&#xD;
             the requirements of the entire study.&#xD;
&#xD;
          -  Abnormal COH screening blood done for both partners, including: prolactin, thyroid&#xD;
             stimulating hormone, HIV serology, Hepatitis B and C serology, Rubella, group and&#xD;
             screen and syphilis serology prior to participation in study.&#xD;
&#xD;
          -  Unwillingness to give written informed consent. Previous entry into this study or&#xD;
             simultaneous participation in another clinical trial.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>27 Years</minimum_age>
    <maximum_age>43 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hillel Yaffe Medical Center</name>
      <address>
        <city>Hadera</city>
        <zip>38100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <contact>
      <last_name>Ofer Fainaru, MD</last_name>
      <phone>972-4-6304750</phone>
      <email>ofer.fainaru@hy.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Adrian Ellenbogen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2010</verification_date>
  <study_first_submitted>March 8, 2010</study_first_submitted>
  <study_first_submitted_qc>March 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2010</study_first_posted>
  <last_update_submitted>March 16, 2010</last_update_submitted>
  <last_update_submitted_qc>March 16, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 18, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. Adrian Ellenbogen</name_title>
    <organization>Hillel Yaffe Medical Center, IVF Unit</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

